Association of cardiometabolic risks with body composition in hemodialysis patients

Basit Öğe Kaydı
dc.authorid0000-0002-7618-0859en_US
dc.contributor.authorArslan, Nurgül
dc.date.accessioned2023-10-05T12:40:12Z
dc.date.available2023-10-05T12:40:12Z
dc.date.issued2023en_US
dc.departmentDicle Üniversitesi, Atatürk Sağlık Bilimleri Fakültesi, Beslenme ve Diyetetik Bölümüen_US
dc.description.abstractOBJECTIVE: High body fat ratio is known as one of the main reasons that increase the risk of cardiovascular disease. This study examined the relationship between body composition and cardiometabolic risks in hemodialysis (HD) patients. PATIENTS AND METHODS: This study was conducted with chronic kidney disease (CKD) patients who received HD treatment between March 2020 and September 2021. Anthropometric measurements of the individuals and their body composition analyses were performed using the bioelectrical impedance analysis (BIA) method. Framingham risk scores were calculated in order to determine the cardiometabolic risk factors of individuals. RESULTS: According to the Framingham risk score, 15.96% of individuals were found to have a high cardiometabolic risk. The lean-fat tissue index (LTI)/(FTI), body shape index (BSI) and visceral adiposity index (VAI) (female-male) values of individuals with high risk according to the Framingham risk score were found to be 11.34±2.29, 13.52±2.88, 8.50±3.89, 9.60±3.07, 0.086±0.024, respectively. The effect of anthropometric measurements in estimating the Framingham risk score was examined using the linear regression analysis. The regression analysis performed with BMI, LTI, VAI values, it was determined that 1-unit increase in VAI increased the Framingham risk score by 1,468 units (OR: 0.951-1.952) (p=0.002). CONCLUSIONS: It has been discovered that indices indicating adipose tissue increase the Framingham risk score in HD patients, independent of BMI. It is recommended to evaluate the ratios showing body fat ratio in cardiovascular diseases.en_US
dc.identifier.citationArslan, N. (2023). Association of cardiometabolic risks with body composition in hemodialysis patients. European Review for Medical and Pharmacological Sciences, 27(6), 2469-2476.en_US
dc.identifier.doi10.26355/eurrev_202303_31780
dc.identifier.endpage2476en_US
dc.identifier.issn1128-3602
dc.identifier.issue6en_US
dc.identifier.pmid37013764
dc.identifier.scopus2-s2.0-85151675332
dc.identifier.scopusqualityQ2
dc.identifier.startpage2469en_US
dc.identifier.urihttps://www.europeanreview.org/article/31780
dc.identifier.urihttps://hdl.handle.net/11468/12752
dc.identifier.volume27en_US
dc.identifier.wosWOS:000971936600031
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.institutionauthorArslan, Nurgül
dc.language.isoenen_US
dc.publisherVerduci Editore s.r.len_US
dc.relation.ispartofEuropean Review for Medical and Pharmacological Sciences
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectCardiometabolic risksen_US
dc.subjectFat tissueen_US
dc.subjectFramingham risk scoreen_US
dc.subjectHemodialysisen_US
dc.subjectLean tissueen_US
dc.titleAssociation of cardiometabolic risks with body composition in hemodialysis patientsen_US
dc.titleAssociation of cardiometabolic risks with body composition in hemodialysis patients
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
Association of cardiometabolic risks with body composition in hemodialysis patients.pdf
Boyut:
375.18 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Makale Dosyası
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

Atatürk Sağlık Bilimleri Fakültesi Beslenme ve Diyetetik Bölümü Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu